Bauer C H, Vischer P, Grünholz H, Reutter W
Cancer Res. 1977 May;37(5):1513-8.
The following three parameters were studied in Morris hepatomas of different growth rates: (a) the specific activity of guanosine dephosphate (GDP)-fucose:glycoprotein fucosyltransferase and cytidine monophosphate (CMP)-N-acetylneuraminic acid:glycoprotein sialyltransferase, (B) the content of GDP-fucosee and CMP-N-acetylneuraminic acid, and (c) the activity of alpha-L-fucosidase and neuraminidase. Fucosyltrasferase activities were significantly elevated in all hepatomas investigated. Especially high levels of enzyme were measured in the rapidly growing tumors 7777, 66, and 3924A. The increase varied between 2- and 3-fold when compared with the corresponding host liver. Conversely, the activity of the sialytransferase was greatly decreased in all hepatoma lines with a rapid or intermediate growth rate. In the fast-growing tumor 9618A2, the activity was reduced to 8%. GDP-fucose and CMP-N-acetylneuraminic acid were determined by the isotope dilution technique. In normal rat liver from Buffalo or ACl rats, the concentration of GDP-fucose was 6.5+/-0.9 and 9.5+/-1.1nmoles/g, wet weight, respectively. In the fast-growing hepatomas 3924A and 9121, levels up to 21.5 nmoles/g, wet weight, were found, However, the content of CMP-N-acetylneuraminic acid in hepatomas was indluenced to a lesser extent by the degree of differentiation of the tumor. In the most rapidly growing tumor, 9618A2, a level of alpha-L- fucosidase seven times higher than in host liver was determined. Moreover, there existed a correlation bewteen the age of the hepatoma and enzyme activity. Within the 2nd week after inoculation, fucosidase activity increased from 130 to 343 nmoles/hr/mg of protein. Neuraminidase was measured in a new linked assay system. The activity of this enzyme was lowered by 50% or was at least unchanged when compared to the activity in host liver. Our results indicate that specific alterations of fucose metabolism are a characteristic feature of Morris hepatomas.
(a) 鸟苷二磷酸(GDP)-岩藻糖:糖蛋白岩藻糖基转移酶和胞苷一磷酸(CMP)-N-乙酰神经氨酸:糖蛋白唾液酸转移酶的比活性;(b) GDP-岩藻糖和CMP-N-乙酰神经氨酸的含量;(c) α-L-岩藻糖苷酶和神经氨酸酶的活性。在所研究的所有肝癌中,岩藻糖基转移酶活性均显著升高。在快速生长的肿瘤7777、66和3924A中测得的酶水平尤其高。与相应的宿主肝脏相比,增加幅度在2至3倍之间。相反,在所有生长迅速或中等的肝癌细胞系中,唾液酸转移酶的活性大大降低。在快速生长的肿瘤9618A2中,活性降至8%。GDP-岩藻糖和CMP-N-乙酰神经氨酸通过同位素稀释技术测定。在布法罗大鼠或ACl大鼠的正常肝脏中,GDP-岩藻糖的浓度分别为6.5±0.9和9.5±1.1纳摩尔/克湿重。在快速生长的肝癌3924A和9121中,发现含量高达21.5纳摩尔/克湿重。然而,肝癌中CMP-N-乙酰神经氨酸的含量受肿瘤分化程度的影响较小。在生长最快的肿瘤9618A2中,测定的α-L-岩藻糖苷酶水平比宿主肝脏高7倍。此外,肝癌的年龄与酶活性之间存在相关性。接种后第2周内,岩藻糖苷酶活性从130增加到343纳摩尔/小时/毫克蛋白质。神经氨酸酶在一种新的连锁测定系统中进行测定。与宿主肝脏中的活性相比,该酶的活性降低了50%或至少没有变化。我们的结果表明,岩藻糖代谢的特定改变是莫里斯肝癌的一个特征。